Pharmaceuticals Product Development | Pharmaceuticals & Biotechnology > Pharmaceuticals Industry | Business solutions from AllBusiness.com
Facebook Twitter You Tube RSS Feed
Related

Journals By Industry - Pharmaceuticals Product Development

Choose your industry from the list to the left.

Today's Must Read
Men taking MDV3100 lived for a median of 18.4 months, compared with 13.6 months for men taking placebo (p < 0.0001; HR=0.631); MDV3100 also met all secondary endpoints, including radiographic progression-free survival (8.3...
Business Journal
This treatment regimen has been shown to improve recurrence-free survival, or RFS, and overall survival, or OS, for KIT+ GIST patients compared to 12 months of treatment. The US approval was based on...
Business Journal
Publication: LexisNexis | Filed In: Cystic Fibrosis and Genetic Diseases
KALYDECO is approved for people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was granted...
Business Journal
CGEN-15001, CGEN-15021 and CGEN-15091 are predicted B7/CD28-like proteins discovered using the company's Protein Family Members Discovery Platform. The company reported that in the collagen induced arthritis model of RA, treatments with either CGEN-15001...
Business Journal
Publication: LexisNexis | Filed In: Statistical Method and Mathematics
Both pivotal Phase III studies are fully recruited, and all patients have been treated, reached the primary endpoint and are in long-term follow-up. The study met all primary, secondary and tertiary efficacy endpoints....
Business Journal
Publication: LexisNexis | Filed In: Medicare and Government Health Insurance
Peters brings more than 25 years of health care experience in marketing, market access and reimbursement, and business development positions. Most recently, Peters was vice president of US payers and national accounts, corporate...
Business Journal
By Simmons, Christopher Laird | Publication: Send2Press Newswire | Filed In: Pharmaceutical Preparation Mfg and Pharmaceuticals & Medicines Manufacturing
HIGHLAND PARK, N.J., Feb. 1, 2012 (SEND2PRESS NEWSWIRE) -- 2012 marks an important milestone for Belvidere Pharmacy. It opened new doors in its new hometown of Highland Park. When owner and President Shara...
Business Journal
Publication: LexisNexis | Filed In: Kidney Disease and Urogenital Disorders
In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease, or CKD, and major vascular events were reduced in the treatment group compared to placebo. The...
Business Journal
Publication: LexisNexis | Filed In: Shareholders and Shareholders & Governance
The company has also announced the assignment of US co-promotion rights to AQUORAL, an FDA-cleared, prescription-only spray for the treatment of Xerostomia, or the medical term for dry mouth due to a lack...
Business Journal
The option agreement provides Navidea with exclusive rights for a period of up to six months to perform final due diligence and prepare the documentation necessary to enter into a definitive license agreement...
Business Journal
Publication: LexisNexis | Filed In: Epilepsy and Neurological Disorders
Keppra was previously approved in the US as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy. The approval was based on data from...
Business Journal
Results from the trial, expected in 2014, could potentially impact atrial fibrillation treatment guidelines by providing further clinical evidence regarding the benefits of the Arctic Front system in treating a largely underserved patient...
Business Journal
Publication: LexisNexis | Filed In: Antivirals and Anti-Infectives
GS-7340 is a novel prodrug of tenofovir, the active agent in Viread, or tenofovir disoproxil fumarate. In previous studies, GS-7340 has demonstrated the ability to provide greater antiviral efficacy at a dose that...
Business Journal
Publication: LexisNexis | Filed In: Cancer and Diseases & Disorders
The study has enrolled 41 patients who progressed on at least one prior chemotherapy regimen that included a platinum compound, or cisplatin, oxaliplatin, or carboplatin, and a fluoropyrimidine compound, or 5-fluorouracil [5-FU] or...
Business Journal
Publication: LexisNexis | Filed In: Mergers & Acquisitions and Ownership Changes
NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated license agreement with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company, while...
Business Journal
Publication: LexisNexis | Filed In: Litigation and Legal Services
The Medicines Company (MDCO) has settled the lawsuits filed in the US district court for the district of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP)...
Business Journal
Publication: LexisNexis | Filed In: Licensing Agreements and Contracts Law
NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated its license agreements with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company,...
Business Journal
Eli Lilly and Co. is pouring more money than ever into its research and development pipeline, but Wall Street has been rewarding companies that cut such spending, according to a recent report by...
Business Journal
By Graves, Brad | Publication: San Diego Business Journal | Filed In: Internet Audio and Software Services & Applications
A key part of founding a company is knowing when to quit. Persistence is an admirable trait, says Michael Robertson, who has founded several companies. However, "there's a fine line between persistence and...
Business Journal

TRENDING NOW:   Save. Spend. Do.,  Free Downloads!,  Credit Crunch Plagues Small Businesses,  Business Resource Center,
BootCamps